For the quarter ended March 2025, Celanese (CE) reported revenue of $2.39 billion, down 8.5% over the same period last year. EPS came in at $0.57, compared to $2.08 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $2.26 billion, representing a surprise of +5.49%. The company delivered an EPS surprise of +54.05%, with the consensus EPS estimate being $0.37.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net Sales- Acetyl Chain: $1.12 billion versus the five-analyst average estimate of $1.08 billion. The reported number represents a year-over-year change of -11.5%. Net Sales- Inter segment eliminations: -$14 million versus -$25.25 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -50% change. Net Sales- Engineered Materials: $1.29 billion versus $1.18 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -6.6% change. Operating EBITDA- Acetyl Chain: $229 million versus $245.41 million estimated by five analysts on average. Operating EBITDA- Other Activities: -$50 million versus -$55.99 million estimated by five analysts on average. Operating EBITDA- Engineered Materials: $235 million versus the five-analyst average estimate of $197.28 million.

View all Key Company Metrics for Celanese here>>>

Shares of Celanese have returned +12.1% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Celanese Corporation (CE):Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

View Comments